Oklahoma 2022 Regular Session

Oklahoma Senate Bill SB1440 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3		-	ENGR. S. B. NO. 1440 Page 1 1
	3	+	SENATE FLOOR VERSION - SB1440 SFLR Page 1
	4	+	(Bold face denotes Committee Amendments) 1
4	5		2
5	6		3
6	7		4
7	8		5
8	9		6
9	10		7
10	11		8
11	12		9
12	13		10
13	14		11
14	15		12
15	16		13
16	17		14
17	18		15
18	19		16
19	20		17
20	21		18
21	22		19
22	23		20
23	24		21
24	25		22
25	26		23
26	27		24
27	28
28		-	~~ENGROSSED~~ SENATE
29		-	~~BILL NO.~~ ~~1440 By: Jech of the Senate~~
	29	+	SENATE FLOOR VERSION
	30	+	February 8, 2022
30	31
31		-	and
32	32
33		-	~~Echols of the House~~
	33	+	SENATE BILL NO. 1440 By: Jech
34	34
35	35
36	36
37	37
38		-	[ Uniform Controlled Dange rous Substances Act -
39		-	certain registration fee -
40		-	emergency ]
41	38
	39	+	An Act relating to the Uniform Controlled Dange rous
	40	+	Substances Act; amending 63 O.S. 202 1, Section 2-303,
	41	+	which relates to the registration and regulation of
	42	+	manufacture, distribution, dispensing, prescribing,
	43	+	administering, and using for scientific purposes of
	44	+	controlled dangerous substances; increasing certain
	45	+	registration fee; updating statutory reference; and
	46	+	providing an effective date .
42	47
43	48
44	49
45	50
46	51		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
47	52		SECTION 1. AMENDATORY 63 O.S. 2021, Section 2 -303, is
48	53		amended to read as follows:
49	54		Section 2-303. A. The Director of the Oklahoma State Bureau of
50	55		Narcotics and Dangerous Drugs Control shall regist er an applicant to
51	56		own a medical facility as described in subsection C of Section 2 -302
52	57		of this title, or to manufacture, distribu te, dispense, prescribe,
53	58		administer or use for scientific purposes controlled dangerous
54	59		substances included in Schedules I thr ough V of Section 2-101 et
55	60		seq. of this title unless the Director determines that the issuance
56	61		of such registration is inconsisten t with the public interest. In
57	62		determining the public interest, the following factors shall be
58	63		considered:
59		-	1. Maintenance of effective controls against diversi on of
60		-	particular controlled dangerous substances and any Schedule I or II
61	64
62		-	ENGR. S. B. NO. 1440 Page 2 1
	65	+	SENATE FLOOR VERSION - SB1440 SFLR Page 2
	66	+	(Bold face denotes Committee Amendments) 1
63	67		2
64	68		3
65	69		4
66	70		5
67	71		6
68	72		7
69	73		8
70	74		9
71	75		10
72	76		11
73	77		12
74	78		13
75	79		14
76	80		15
77	81		16
78	82		17
79	83		18
80	84		19
81	85		20
82	86		21
83	87		22
84	88		23
85	89		24
86	90
	91	+	1. Maintenance of effective controls against diversion of
	92	+	particular controlled dangerous substances and any Schedule I or II
87	93		substance compounded therefrom into other than legitimate medic al,
88	94		scientific or industrial channels , including examination of the
89	95		fitness of his or her employees or agents to handle dangerous
90	96		substances;
91	97		2. Compliance with applicable state and local law;
92	98		3. Has been found g uilty of, entered a plea of guilty or nolo
93	99		contendere to a charge under the Uniform Controlled Dangerous
94	100		Substances Act or any other state or federal law relating to any
95	101		substance defined herein as a controlled dangerous substance or any
96	102		felony under the laws of any state or the United States;
97	103		4. Furnishing by the applicant false or fraudulent material
98	104		information in any applica tion filed under Section 2-101 et seq. of
99	105		this title;
100	106		5. Past experience in the manufacture, distribution,
101	107		dispensing, prescribin g, administering or use for scientific
102	108		purposes of controlled dangerous substances, and the existence in
103	109		the establishment of effective controls against diversion;
104	110		6. Denial, suspension or revocation of the applicant ’s federal
105	111		registration to manufacture, distribute or dispense controlled
106	112		dangerous substances as authorized by federal law; and
107	113		7. Such other factors as may be rel evant to and consistent with
108	114		the public health and safety.
109	115
110		-	ENGR. S. B. NO. 1440 Page 3 1
	116	+	SENATE FLOOR VERSION - SB1440 SFLR Page 3
	117	+	(Bold face denotes Committee Amendments) 1
111	118		2
112	119		3
113	120		4
114	121		5
115	122		6
116	123		7
117	124		8
118	125		9
119	126		10
120	127		11
121	128		12
122	129		13
123	130		14
124	131		15
125	132		16
126	133		17
127	134		18
128	135		19
129	136		20
130	137		21
131	138		22
132	139		23
133	140		24
134	141
135	142		Nothing herein shall be deemed to require individual licensed
136	143		pharmacists to register under the provisions of the Uniform
137	144		Controlled Dangerous Substances Act.
138	145		B. Registration granted under subsect ion A of this section
139	146		shall not entitle a registrant to manufacture, distribute, dispense,
140	147		prescribe, administer or use for scient ific purposes controlled
141	148		dangerous substances in Schedule I or II other than those specified
142	149		in the registration.
143	150		C. Practitioners shall be registered to dispense, prescribe,
144	151		administer or use for scientific purposes substances in Schedules II
145	152		through V if they are authorized to carry on their re spective
146	153		activities under the laws of this state. A registration application
147	154		by a practitioner who wishes to conduct research with Schedule I
148	155		substances shall be accompanied by evidence of the applicant ’s
149	156		federal registration to conduct such activity and shall be referred
150	157		to the Medical Research Commission for advice. The Medical Resear ch
151	158		Commission shall promptly advise the Director concerning the
152	159		qualifications of each practitioner requesting such registration.
153	160		Registration for the purpose of bona fide research or of use for
154	161		scientific purposes with Schedule I substances by a practiti oner
155	162		deemed qualified by the Medical Research Commission may be denied
156	163		only on a ground specified in subsection A of Section 2 -304 of this
157	164		title or if there are reasonable grounds to believe that the
158	165		applicant will abuse or unlawfully transfer such substan ces or fail
159	166
160		-	ENGR. S. B. NO. 1440 Page 4 1
	167	+	SENATE FLOOR VERSION - SB1440 SFLR Page 4
	168	+	(Bold face denotes Committee Amendments) 1
161	169		2
162	170		3
163	171		4
164	172		5
165	173		6
166	174		7
167	175		8
168	176		9
169	177		10
170	178		11
171	179		12
172	180		13
173	181		14
174	182		15
175	183		16
176	184		17
177	185		18
178	186		19
179	187		20
180	188		21
181	189		22
182	190		23
183	191		24
184	192
185	193		to safeguard adequately such applicant ’s supply of such substances
186	194		against diversion from legitimate medical or scient ific use.
187	195		D. 1. The Director shall initi ally permit persons to register
188	196		who own or operate any establishment engaged in the manufacture,
189	197		distribution, dispensing, prescribing, administering or use for
190	198		scientific purposes of any controlled dangerous subst ances prior to
191	199		June 4, 1991, and who are r egistered or licensed by the state. Fees
192	200		for registration under this section shall be as follows:
193	201		Practitioners and mid-level
194	202		practitioners $140.00 per year
195	203		of registration
196	204		Home Care Agencies, Hospices &
197	205		Home Care Services $140.00 annually
198	206		Medical Facility Owners $300.00 annually
199	207		Distributors $300.00 annually
200	208		Manufacturers $500.00 $2,500.00 annually
201	209		Manufacturer, Wholesaler, or
202	210		Distributor of drug products
203	211		containing pseudoephedrine
204	212		or phenylpropanolamine $300.00 annually
205	213		2. A registrant shall be require d to pay double the amount of
206	214		the above-listed fee for any renewal of registration r eceived more
207	215		than thirty (30) days late.
208	216
209		-	ENGR. S. B. NO. 1440 Page 5 1
	217	+	SENATE FLOOR VERSION - SB1440 SFLR Page 5
	218	+	(Bold face denotes Committee Amendments) 1
210	219		2
211	220		3
212	221		4
213	222		5
214	223		6
215	224		7
216	225		8
217	226		9
218	227		10
219	228		11
220	229		12
221	230		13
222	231		14
223	232		15
224	233		16
225	234		17
226	235		18
227	236		19
228	237		20
229	238		21
230	239		22
231	240		23
232	241		24
233	242
234	243		3. A Ten Dollar ($10.00) fee shall be charged for a duplicate
235	244		registration certificate.
236	245		E. Compliance by manufacturers and distri butors with the
237	246		provisions of the Federal Controlled Substances Act, 21 U.S.C.,
238	247		Section 801 et seq., respecting registration, excluding fees, shall
239	248		be deemed sufficient to qualify for registration under this act
240	249		Section 2-101 et seq. of this title .
241		-	SECTION 2. It being immediately necessary for the pr eservation
242		-	of the public peace, health or safety, an emer gency is hereby
243		-	declared to exist, by reason whereof this act shall take effect and
244		-	be in full force from and after its passage and approval.
245		-	Passed the Senate the 23rd day of March, 2022.
246		-
247		-
248		-
249		-	Presiding Officer of the Senate
250		-
251		-
252		-	Passed the House of Represen tatives the ____ day of __________,
253		-	2022.
254		-
255		-
256		-
257		-	Presiding Officer of the House
258		-	of Representatives
259		-
	250	+	SECTION 2. This act shall become effec tive November 1, 2022.
	251	+	COMMITTEE REPORT BY: COMMITTEE ON FINANCE
	252	+	February 8, 2022 - DO PASS